OPEN END TURBO OHNE STOP-LOSS - DEXCOM | Real-time Bid/Ask 10:11:36 01/07/2024 BST | ||
| 4.1 EUR / 4.2 EUR | +1.47% |
|
| Current month | -7.26% | ||
| 1 month | -24.12% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
DEXCOM, INC.
| Date | Price | Change |
|---|---|---|
| 01/07/24 | 4.15 | +1.47% |
| 28/06/24 | 4.09 | -5.76% |
| 27/06/24 | 4.34 | +2.60% |
| 26/06/24 | 4.23 | +8.74% |
| 25/06/24 | 3.89 | -0.26% |
Delayed Quote Börse Stuttgart
Last update July 01, 2024 at 07:14 am
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | DEXCOM, INC. |
| Issuer | Lang & Schwarz |
| WKN | LX3J67 |
| ISIN | DE000LX3J673 |
| Date issued | 16/10/2023 |
| Strike | 66.21 € |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.15 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 6.91 € |
|---|---|
| Lowest since issue | 1.1 € |
| Spread | 0.1 € |
| Spread % | 2.39% |
Company Profile
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals.
The United States accounts for 72.5% of net sales.
Sector
-
Consensus: DexCom, Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
113.4
USD
Average target price
150.3
USD
Spread / Average Target
+32.60%
- Stock Market
- Certificates
- Certificat
